
Results
12
Companies which are more than 50% undervalued based on analyst price target.
12 companies
Daiichi Sankyo Company
Market Cap: JP¥4.8t
Manufactures and sells pharmaceutical products in Japan and internationally.
4568
JP¥2,679.50
7D
-1.5%
1Y
-21.4%
Sumitomo Pharma
Market Cap: JP¥602.0b
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥1,342.00
7D
-12.0%
1Y
32.1%
GNI Group
Market Cap: JP¥169.8b
Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.
2160
JP¥2,580.00
7D
-8.8%
1Y
-15.1%
PeptiDream
Market Cap: JP¥129.3b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥1,006.50
7D
-3.5%
1Y
-37.8%
Nxera Pharma
Market Cap: JP¥84.1b
Operates as a biopharmaceutical company, engages in drug discovery and development in Japan, the United States, Germany, Switzerland, Bermuda, the United Kingdom, and internationally.
4565
JP¥908.00
7D
-4.9%
1Y
4.2%
SanBio
Market Cap: JP¥78.7b
Engages in the development, production, and sale of regenerative cell medicines for the central nervous system in Japan and the United States.
4592
JP¥1,008.00
7D
-1.5%
1Y
-52.8%
Heartseed
Market Cap: JP¥36.4b
Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.
219A
JP¥1,593.00
7D
-2.9%
1Y
-49.7%
Healios K.K
Market Cap: JP¥35.2b
Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.
4593
JP¥261.00
7D
8.3%
1Y
-48.8%
StemRIM
Market Cap: JP¥19.0b
A biotechnology company, researches and develops regeneration-inducing medicine in Japan and internationally.
4599
JP¥303.00
7D
-2.3%
1Y
2.4%
Kidswell Bio
Market Cap: JP¥7.5b
Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.
4584
JP¥151.00
7D
1.3%
1Y
-43.9%
Noile-Immune Biotech
Market Cap: JP¥5.8b
Researches and develops CAR-T cells for novel cancer immunotherapies.
4893
JP¥134.00
7D
5.5%
1Y
-22.5%
TMS
Market Cap: JP¥4.7b
Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.
4891
JP¥103.00
7D
-1.0%
1Y
-39.1%